Skip to content

    Revolution Medicines, Inc.

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Trend
    EarningsRevenue
    $0
    $0
    $0
    Operating Profit
    -$156.64M
    -$175.71M
    -$216.31M
    -$240.76M
    -$264.71M
    -69.0%
    -$315.27M
    -79.4%
    -$361.63M
    -67.2%
    -$445.22M
    -84.9%
    Weakening
    Net Profit
    -$133.23M
    -$156.29M
    -$194.57M
    -$213.42M
    -$247.79M
    -86.0%
    -$305.21M
    -95.3%
    -$364.89M
    -87.5%
    -$453.82M
    -112.6%
    Weakening
    EPS
    $-0.81
    $-0.94
    $-1.13
    $-1.31
    -61.7%
    $-1.61
    -71.3%
    $-2.29
    -102.7%
    Weakening
    Other Income
    $23.41M
    $19.42M
    $20.99M
    $27.34M
    $16.93M
    -27.7%
    $10.06M
    -48.2%
    -$3.27M
    -115.6%
    -$8.59M
    -131.4%
    Weakening
    Interest
    $0
    $0
    $11.43M
    $12.20M
    Strengthening
    Depreciation
    Profit before Tax
    -$133.23M
    -$156.29M
    -$195.32M
    -$213.42M
    -$247.79M
    -86.0%
    -$305.21M
    -95.3%
    -$364.89M
    -86.8%
    -$453.82M
    -112.6%
    Weakening
    MarginsOPM
    Tax
    0.0%
    0.0%
    0.4%
    ReturnsROIC
    2.8%
    3.3%
    4.1%
    4.5%
    5.2%
    +86.0%
    6.4%
    +95.3%
    7.6%
    +87.5%
    9.5%
    +112.6%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$69.59M$16.66M$104.27M$108.50M$161.41M$696.15M$543.06M$383.75M$440.94M
    Short-Term Investments$106.10M$336.47M$468.56M$483.53M$1.16B$1.75B$1.64B$1.47B
    Total Current Assets$133.98M$454.12M$589.77M$660.18M$1.88B$2.33B$2.08B$1.97B
    Net PP&E$7.15M$36.34M$71.24M$73.74M$100.01M$141.82M$165.28M$161.37M
    Goodwill$14.61M$14.61M$14.61M$14.61M$14.61M$14.61M$14.61M$14.61M
    Intangibles$62.01M$60.95M$59.88M$58.81M$57.74M$56.67M$55.80M$55.80M
    Total Assets$220.53M$567.40M$737.99M$811.93M$2.06B$2.56B$2.35B$2.25B
    LiabilitiesTotal Current Liabilities$43.05M$47.18M$60.35M$61.98M$143.85M$163.91M$290.42M$289.60M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$28.99M$60.42M$57.43M$80.58M$122.97M$142.23M$140.02M
    Total Liabilities$67.99M$92.72M$135.42M$126.74M$235.51M$293.10M$723.21M$753.82M
    EquityCommon Stock & APIC$7.0K$8.0K$9.0K$16.0K$18.0K$19.0K$19.0K
    Retained Earnings-$157.39M-$265.55M-$452.64M-$701.34M-$1.14B-$1.74B-$2.87B-$3.32B
    Total Equity-$108.42M-$152.57M$474.68M$602.57M$685.19M$1.83B$2.27B$1.63B$1.50B
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$1.21M-$49.62M-$100.06M-$147.18M-$224.40M-$350.57M-$557.44M-$897.74M-$1.06B
    Cash from Investing-$1.34M-$101.97M-$234.23M-$142.12M-$24.12M-$342.60M-$554.39M$118.06M$306.62M
    Cash from Financing$60.85M$98.66M$422.78M$294.18M$301.43M$1.23B$959.41M$621.52M$859.39M
    SummaryCapital Expenditure-$1.50M-$2.59M-$2.93M-$6.53M-$10.82M-$7.73M-$10.31M-$15.99M-$14.26M
    Free Cash Flow-$286.0K-$52.20M-$103.00M-$153.71M-$235.22M-$358.30M-$567.74M-$913.73M-$1.07B
    FCF Margin-1.4%-104.3%-239.6%-523.0%-664.8%-3094.1%